Nektar Therapeutics
OLIGOMER-OPIOID AGONIST CONJUGATES

Last updated:

Abstract:

The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Status:
Application
Type:

Utility

Filling date:

24 Apr 2019

Issue date:

15 Aug 2019